SecBot SecBot
3 ·Filed Jun 24, 2026

ADTX

Aditxt, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago SEC0001475597-26-000104
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Monitor for any subsequent Form 4 or Schedule 13D filings from HRT Financial LP that could indicate trading activity or activist intent. The 2.4M share position is sizeable for a micro-cap issuer but no catalyst is signaled by this standalone initial filing.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ADTX ▲ +150.00% at T+60d
NEUTRAL call +150.00% · α vs SPY +146.15% · entry $0.002000 → $0.005000
Entry = T+0 close
Jun 24, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.72%
$0.002000
settled 4mo ago
T+5d
+150.00%
call +150.00% · α +148.57%
$0.005000
settled 4mo ago
T+20d
+100.00%
call +100.00% · α +99.47%
$0.004000
settled 3mo ago
T+60d
+150.00%
call +150.00% · α +146.15%
$0.005000
settled 6w ago

Price Chart

Loading chart...

Executive Summary

HRT Financial LP filed an initial beneficial ownership statement (Form 3) for Aditxt, Inc., indicating a passive stake. HRT Financial LP reports beneficial ownership of 2,406,438 shares of common stock. This is a routine initial ownership disclosure filing with no material new business or financial information.

Key Facts

  • Reporting owner: HRT Financial LP (a Delaware limited partnership, formerly HRT Financial LLC).
  • Period of report: June 18, 2026; filing accepted June 24, 2026.
  • HRT Financial LP reports beneficial ownership of 2,406,438 shares of Aditxt common stock.
  • This is an initial statement of beneficial ownership (Form 3), not an amendment to a prior filing.
  • No indication of activist intent, derivative holdings, or any other material information in the filing.

Financial Impact

No financial impact or transaction disclosed; initial beneficial ownership declaration only.

ownershipshare count

Risk Factors

  • Potential future dilution or selling pressure if HRT Financial LP reduces its position.
  • No business or financial details provided; filing has no predictive content for stock performance.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001475597-26-000104
Document: 0001475597-26-000104-index.html0001475597-26-000104
Document: 0001475597-26-000104.txt0001475597-26-000104
28 reports for ADTX
Performance horizon
92% Hit rate @ T+60 11 of 12 directional calls Went positive at some point 11 of 15 best @ T+60▲ +99.96%Apr 14, 2026
Filters
Rows
Reports for ADTX — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
BEARISH ★ 6/10
$0.009500awaiting T+60—$0.001000 (+89.47%)
Oct 7, 2026
20d ago
25-NSE
BEARISH ★ 8/10
$0.009500awaiting T+60—$0.001000 (+89.47%)
Sep 23, 2026
4w ago
8-K
BEARISH ★ 8/10
$0.009500awaiting T+60—$0.001000 (+89.47%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$0.003000 $0.003000· 0.00%▼ −4.94%$0.001000 (−66.67%)
Jun 24, 2026
17w ago
3
NEUTRAL ★ 2/10
$0.002000 $0.005000▲ +150.00%▲ +146.15%$0.001000 (−50.00%)
Jun 23, 2026
18w ago
8-K
BEARISH ★ 6/10
$0.0100 $0.006000▲ +40.00%▲ +43.29%$0.001000 (+90.00%)
Jun 18, 2026
18w ago
Insider Cluster
BEARISH ★ 7/10
$0.0100 $0.009500▲ +5.00%▲ +6.89%$0.001000 (+90.00%)
Jun 17, 2026
18w ago
Insider Cluster
BEARISH ★ 5/10
$0.0100 $0.009500▲ +5.00%▲ +6.89%$0.001000 (+90.00%)
Jun 17, 2026
18w ago
3
NEUTRAL ★ 2/10
$0.004400 $0.009500▲ +115.91%▲ +112.76%$0.001000 (−77.27%)
Jun 16, 2026
19w ago
Insider Cluster
MIXED ★ 5/10
$0.0109 $0.009500▼ −12.84%▼ −13.84%$0.001000 (−90.83%)
Showing 10 of 28

US Market Status

Market Closed — Opens Thu (12h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 24, 2026